GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Abbreviated name: D3 L-DOPA
Synonyms: DP-102
Compound class:
Synthetic organic
Comment: Chronic treatment with a substantially lower dose of deuterium-substituted L-DOPA (D3-L-DOPA), compared with L-DOPA (levodopa) produced equal anti-parkinsonian effects and reduced dyskinesia in 6-OHDA-lesioned rats [2]. This new rat study reports similar effect produced by D3-L-DOPA and selegiline plus L-DOPA, respectively, implying adjuvant MAO-B inhibitor treatment may not be necessary with D3-L-DOPA [1]. This compound was proposed for development by the Michael J Fox foundation but there is no ClinicalTrials.gov entry.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| (2S)-2-amino-2,3,3-trideuterio-3-(3,4-dihydroxyphenyl)propanoic acid |
Synonyms ![]() |
| DP-102 |
Database Links ![]() |
|
| GtoPdb PubChem SID | 252166812 |
| PubChem CID | 76955701 |
| Search Google for chemical match using the InChIKey | WTDRDQBEARUVNC-QZRTVAIESA-N |
| Search Google for chemicals with the same backbone | WTDRDQBEARUVNC |
| UniChem Compound Search for chemical match using the InChIKey | WTDRDQBEARUVNC-QZRTVAIESA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | WTDRDQBEARUVNC-QZRTVAIESA-N |